In the past, physiological, oncological and pharmaceutical investigations led to the development of different models of enterocutaneous fistulas. For a few years, fistula models were also created to investigate the efficacy of minimal invasive therapies in closing these fistulas. As most experimental surgical procedures are difficult to perform and are often combined with a high mortality or spontaneous closure rate, a new model in mice was developed with the aim of avoiding these disadvantages. Twenty mice, divided into two groups of 10 animals each, had a caecostoma created surgically. The two groups differed regarding the technique of creating the stoma. All animals survived and gained weight during a postoperative period of 4 months. The operation was easy to perform and lasted no longer than about 30 min. Neither a spontaneous closure of the fistula nor any prior death of animals occurred. In conclusion, because of its simplicity and low complication rate, the presented model of an enterocutaneous fistula may offer an interesting alternative to other models for a variety of indications.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s004330050105 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Injectable Nanoengineered Adhesive Hydrogel for Treating Enterocutaneous Fistulas.
Acta Biomater
October 2023
Terasaki Institute for Biomedical Innovation (TIBI), 1018 Westwood Blvd, Los Angeles, California, USA.
Enterocutaneous fistula (ECF) is a severe medical condition where an abnormal connection forms between the gastrointestinal tract and skin. ECFs are, in most cases, a result of surgical complications such as missed enterotomies or anastomotic leaks. The constant leakage of enteric and fecal contents from the fistula site leads to skin breakdown and increases the risk of infection.
View Article and Find Full Text PDF[Construction of a model based on multipoint full-layer puncture biopsy for predicting pathological complete response after neoadjuvant therapy for locally advanced rectal cancer].
Zhonghua Wei Chang Wai Ke Za Zhi
April 2024
Department of General Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
To investigate the value of transanal multipoint full-layer puncture biopsy (TMFP) in predicting pathological complete response (pCR) after neoadjuvant radiotherapy and chemotherapy (nCRT) in patients with locally advanced rectal cancer (LARC) and to establish a predictive model for providing clinical guidance regarding the treatment of LARC. In this multicenter, prospective, cohort study, we collected data on 110 LARC patients from four hospitals between April 2020 and March 2023: Beijing Chaoyang Hospital of Capital Medical University (50 patients), Beijing Friendship Hospital of Capital Medical University (41 patients), Qilu Hospital of Shandong University (16 patients), and Zhongnan Hospital of Wuhan University (three patients). The patients had all received TMFP after completing standard nCRT.
View Article and Find Full Text PDFInjectable Nanoengineered Adhesive Hydrogel for Treating Enterocutaneous Fistulas.
Acta Biomater
January 2024
Terasaki Institute for Biomedical Innovation (TIBI), 1018 Westwood Blvd, Los Angeles, California, USA.
Article Synopsis
- Enterocutaneous fistula (ECF) is a serious condition where an abnormal connection occurs between the gastrointestinal tract and the skin, often due to surgical complications, leading to high mortality and morbidity rates.
- A new injectable nanoengineered adhesive hydrogel (INAH) has been developed, combining synthetic nanosilicate and a gelatin-dopamine conjugate, which shows promise for sealing and healing ECF due to its strong mechanical properties and ability to promote cell growth.
- The INAH has fast cross-linking capabilities, excellent adhesive qualities, and is biocompatible, making it a potentially effective treatment option for patients suffering from ECF.
In situ bioprinting of double network anti-digestive xanthan gum derived hydrogel scaffolds for the treatment of enterocutaneous fistulas.
Carbohydr Polym
February 2024
Research Institute of General Surgery, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing 210008, China; School of Medicine, Southeast University, Nanjing 210009, China. Electronic address:
The clinical treatment of enterocutaneous fistula is challenging and causes significant patient discomfort. Fibrin gel can be used to seal tubular enterocutaneous fistulas, but it has low strength and poor digestion resistance. Based on in situ bioprinting and the anti-digestive properties of xanthan gum (XG), we used carboxymethyl chitosan (CMC) and xanthan gum modified by grafted glycidyl methacrylate (GMA) and aldehyde (GCX) as the ink to print a double network hydrogel that exhibited high strength and an excellent anti-digestive performance.
View Article and Find Full Text PDF3D-Printing Applications in Ostomy Device Creation and Complex Intestinal Fistula Management: A Scoping Review.
Surg J (N Y)
July 2023
Cambridge Colorectal Unit, Cambridge University Hospitals NHS Trust, Cambridge, United Kingdom.
This scoping review aims to provide a summary of the use of three-dimensional (3D) printing in colorectal surgery for the management of complex intestinal fistula and ostomy creation. A systematic database search was conducted of original articles that explored the use of 3D printing in colorectal surgery in EMBASE, MEDLINE, Cochrane database, and Google Scholar, from inception to March 2022. Original articles and case reports that discussed 3D printing in colorectal surgery relating to complex intestinal fistulae and ostomies were identified and analyzed.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!